#	Pagina
attuale pagina	/open-h2020/projects/227668/index.html
-1	/open-h2020/projects/215154/index.html
-2	/open-h2020/per-topic/automatized/list/index.html
-3	/open-h2020/per-topic/progressively/list/index.html
-4	/open-h2020/projects/211338/index.html
-5	/open-h2020/per-topic/trivial/list/index.html
-6	/open-consip/fornitori/2015/profilo-01389060425/index.html
-7	/open-h2020/per-topic/nanoscience/list/index.html
-8	/open-h2020/projects/211875/index.html
-9	/open-h2020/projects/213119/deliverables.html

Opendata, web and dolomites

SmartHeart SIGNED

SmartHeart, a 3D in vitro assay for improved assessment of cardiac drug efficacy and toxicity

Total Cost €

EC-Contrib. €

Partnership

Views

SmartHeart project word cloud

Explore the words cloud of the SmartHeart project. It provides you a very rough idea of what is the project "SmartHeart" about.

clinical expertise gel read human assays answer platforms entering commercial whom trials predict leader diseases physics final feedback compatible multiwell models nature stage drugs retrieve culture angle pharma maturation ethical tune assay commercialized structure candidate fine career standards limiting body shortcomings contractility quantitative imaging acquired pluripotent cardiomyocytes cardiac 4dcell device managerial specifications 3dcell plates animal cellular academic qualitative put ultimate cultured smartheart microstructured calcium currently act minimized mimic hts cms drug proprietary screening efficient simultaneously competences action resolution meet er cros industrial transients technological stem techniques cells vitro 6 maturity hcs closer 3d observation outs sub

Project "SmartHeart" data sheet

The following table provides information about the project.

Coordinator	4DCELL Organization address address: 14 RUE DE LA BEAUNE BAT C ETAGE 2 city: MONTREUIL postcode: 93100 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.
Coordinator Country	France [FR]
Total cost	196˙707 €
EC max contribution	196˙707 € (100%)
Programme	1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
Code Call	H2020-MSCA-IF-2019
Funding Scheme	MSCA-IF-EF-SE
Starting year	2020
Duration (year-month-day)	from 2020-03-02 to 2022-03-01

Partnership

Take a look of project's partnership.

#	participants	country	role	EC contrib. [€]
1	4DCELL 4DCELL Organization address address: 14 RUE DE LA BEAUNE BAT C ETAGE 2 city: MONTREUIL postcode: 93100 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	FR (MONTREUIL)	coordinator	196˙707.00

Map

Project objective

Currently, animal models are still widely used in the pre-clinical stage of drug development to mimic human diseases or predict the human body’s response to candidate drugs. However, their use should be minimized as much as possible due to ethical issues and since only 9.6% of drugs entering phase I of clinical trials end up being commercialized. Therefore, the goal of this action is to develop a novel proprietary 3D in vitro cardiac assay. The SmartHeart will retrieve several of the most important read-outs commonly assessed to study the impact of drugs at the cardiac level in the pre-clinical phase. The all in one assay will be based on a microstructured gel where cardiac cells, as cardiomyocytes derived from induced pluripotent stem cells will be cultured. The SmartHeart will answer to the shortcomings of academic and commercial available in vitro assays, by enabling the qualitative and quantitative measurement of several parameters, as contractility and Calcium transients. Simultaneously, the assay will enable sub-cellular structure observation via high-resolution imaging techniques. Furthermore, the 3D nature of the assay will contribute to the efficient maturation of the induced CMs, which is still a limiting factor when not using cardiac human cells, but rather induced CMs, in in vitro assays. The ultimate aim of the project is to make this device available to screening platforms, e.g. Pharma or CROs. The technology will be implemented in multiwell plates compatible with the standards of HTS/HCS and will be available to early-users, from whom feedback will be acquired, enabling to fine tune the specifications of the final device. This project will meet the best of the ER competences in physics, with the expertise of 4Dcell in 3Dcell culture systems. With this project, the ER will reach a level of maturity on several technological, managerial and industrial aspects providing her a new career angle and put her a step closer to act as a leader in research.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SMARTHEART" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "SMARTHEART" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

PaSION (2018)

A longitudinal assessment of treatment experience, symptoms and potential associations with biomarkers in cancer patients undergoing immune checkpoint inhibitor therapy